Drug Type CAR-T |
Synonyms ASPH targeted CAR-T cell therapy |
Target |
Action inhibitors |
Mechanism HAAH inhibitors(Aspartyl (asparaginyl) β-hydroxylase inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | United States | 10 Feb 2019 | |
| Hematologic Neoplasms | Preclinical | United States | 09 Feb 2019 |





